Ankyrin-B (Ank2; AnkB) is a member of the ankyrin family of membrane adaptors that contributes to the assembly of diverse specialized plasma membrane domains. In humans, the p.L1622I variant, located in the unstructured C-terminal regulatory domain, is the most common ANK2 mutation in African Americans at over 7%, with a presence of less than 0.1% of individuals of mixed European decent. In humans, the mutation is involved with the setting of hereditary cardiac arrhythmia.

These knock-in mice carry the L1622I mutation in the Ank2 gene. Homozygotes develop a metabolic syndrome characterized by early-onset pancreatic β cell dysfunction and age- or diet-dependent increases in adiposity and insulin resistance. Tissue-specific ANK2 deficiency is also observed.

Homozygous mice are born at the expected Mendelian ratios and exhibit no differences in mRNA levels, as assessed by qPCR. Protein levels in homozygotes, however, are reduced significantly in a subset of tissues, including fat, liver, skeletal muscle, pancreatic β cells, and heart. Primary mouse embryonic fibroblast (MEF) cultures also show reduced protein expression. No change in protein expression is detected in the brain.

In contrast to Ank2^{R1788W/R1788W} mutant animals (see Stock No. 027915), islets isolated from Ank2^{L1622I/L1622I} mutant animals respond normally to glucose stimulation. Homozygous Ank2^R1788W mutant mice exhibit over 50% reduction in glucose-stimulated insulin secretion (normalized to total insulin content).

While fasting serum glucose levels are unaltered in both Ank2^R1788W and Ank2^L1622I homozygous mice, oral administration of glucose (2 g/kg body weight) during an oral glucose tolerance test leads to both an increased level of blood glucose at 30 minutes as well as a delay in glucose clearance. The areas under the blood glucose response curves are significantly increased by 2- and 1.7 fold in homozygous Ank2^R1788W and Ank2^L1622I knock-in mice, respectively. Heterozygotes demonstrate 1.8- and 1.4-fold increases, respectively.

Both 3-month-old and 10-month-old Ank2^R1788W and Ank2^L1622I homozygous mice show overall similar average rates of food intake, energy source utilization, and activity compared with littermate controls during both light and dark cycles.

Both Ank2^R1788W and Ank2^L1622I homozygous mutant mice exhibit
significant adipocyte hypertrophy (54% increase in adipocyte diameter in Ank2^R1788W and 38% in Ank2^L1622I mice) which is accompanied by elevated levels of circulating nonesterified fatty acids. The increase in body fat is more prominent than the overall changes in total body weight.

It has not been determined whether mice carrying the Ank2^L1622I mutation have a cardiac phenotype.